QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
QQQ   418.16 (-1.24%)
AAPL   165.09 (-1.17%)
MSFT   401.25 (-0.75%)
META   486.98 (-2.95%)
GOOGL   154.68 (-0.85%)
AMZN   176.21 (-1.68%)
TSLA   149.84 (-0.06%)
NVDA   820.55 (-3.09%)
AMD   149.77 (-3.42%)
NIO   3.86 (-3.50%)
BABA   68.95 (+0.10%)
T   16.33 (+0.00%)
F   12.12 (+0.50%)
MU   107.30 (-4.14%)
GE   150.77 (-1.42%)
CGC   8.04 (+2.68%)
DIS   111.81 (-0.55%)
AMC   3.19 (+9.25%)
PFE   25.76 (+1.46%)
PYPL   62.17 (+0.11%)
XOM   120.03 (+1.27%)
NASDAQ:LSAQ

LifeSci Acquisition II (LSAQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$9.01
$14.10
52-Week Range
N/A
Volume
N/A
Average Volume
53,514 shs
Market Capitalization
$57.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About LifeSci Acquisition II

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

LSAQ Stock News Headlines

Start loving Mondays like this
Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Lifesci Acquisition II Corp (LSAQ)
See More Headlines
Receive LSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeSci Acquisition II and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:LSAQ
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.50 per share

Miscellaneous

Free Float
N/A
Market Cap
$57.56 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Andrew Ian McDonald Ph.D. (Age 47)
    Chairman & CEO
  • Mr. David Dobkin (Age 42)
    CFO, Head of Strategy & Director
  • Mr. Michael Yehuda Rice (Age 56)
    COO & Director

LSAQ Stock Analysis - Frequently Asked Questions

When did LifeSci Acquisition II IPO?

LifeSci Acquisition II (LSAQ) raised $75 million in an initial public offering on Friday, November 20th 2020. The company issued 7,500,000 shares at a price of $10.00 per share. LifeSci Capital and Ladenburg Thalmann acted as the underwriters for the IPO.

This page (NASDAQ:LSAQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners